(Q46808074)

25 December 2017

title

Neurochemical effects of olanzapine in first-hospitalization manic adolescents: a proton magnetic resonance spectroscopy study (English)

1 reference

25 December 2017

1 reference

1 reference

2

1 reference

25 December 2017

Melissa P DelBello

1

object named as

Melissa P DelBello

1 reference

25 December 2017

author name string

Caleb M Adler

3

1 reference

25 December 2017

John P Daniels

4

1 reference

25 December 2017

Stephen M Strakowski

5

1 reference

25 December 2017

language of work or name

English

0 references

publication date

1 June 2006

1 reference

25 December 2017

published in

Neuropsychopharmacology

1 reference

25 December 2017

volume

31

1 reference

25 December 2017

issue

6

1 reference

25 December 2017

page(s)

1264-1273

1 reference

25 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300950

exact match

0 references

cites work

A rating scale for drug-induced akathisia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300950

Medication use in children and adolescents treated in the community for bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300950

Significance of adolescent neurodevelopment for the neural circuitry of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300950

Cellular mechanisms and second messengers: relevance to the psychopharmacology of bipolar disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300950

Role of the cholinergic muscarinic system in bipolar disorder and related mechanism of action of antipsychotic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300950

Muscarinic mechanisms of antipsychotic atypicality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300950

Frontal lobe differences in bipolar disorder as determined by proton MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300950

Proton magnetic resonance spectroscopy of the frontal lobe and cerebellar vermis in children with a mood disorder and a familial risk for bipolar disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300950

Decreased N-acetylaspartate in children with familial bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300950

Anomalous prefrontal-subcortical activation in familial pediatric bipolar disorder: a functional magnetic resonance imaging investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300950

Mood stabilizer augmentation with olanzapine in acutely manic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300950

Brain metabolic alterations in medication-free patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300950

Decreased anterior cingulate myo-inositol/creatine spectroscopy resonance with lithium treatment in children with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300950

A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300950

The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300950

Double-blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300950

A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300950

The Mania Rating Scale: can it be used in children? A preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300950

Reliability of the Washington University in St. Louis Kiddie Schedule for Affective Disorders and Schizophrenia (WASH-U-KSADS) mania and rapid cycling sections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300950

An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300950

Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300950

Oral choline decreases brain purine levels in lithium-treated subjects with rapid-cycling bipolar disorder: a double-blind trial using proton and lithium magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300950

Nerve growth factor in never-medicated first-episode psychotic and medicated chronic schizophrenic patients: possible implications for treatment outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300950

Differential effects of typical and atypical antipsychotics on nerve growth factor and choline acetyltransferase expression in the cortex and nucleus basalis of rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300950

Modulation of nerve growth factor and choline acetyltransferase expression in rat hippocampus after chronic exposure to haloperidol, risperidone, and olanzapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300950

Divalproex sodium for pediatric mixed mania: a 6-month prospective trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300950

Automatic quantitation of localized in vivo 1H spectra with LCModel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300950

Polymorphism of the brain-derived neurotrophic factor gene and performance on a cognitive prefrontal test in bipolar patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300950

A children's global assessment scale (CGAS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300950

Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetyl-aspartate concentrations in euthymic bipolar patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300950

Choline in the treatment of rapid-cycling bipolar disorder: clinical and neurochemical findings in lithium-treated patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300950

Erythrocyte choline concentrations in psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300950

The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300950

A rating scale for mania: reliability, validity and sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300950

Linkage Disequilibrium of the Brain-Derived Neurotrophic FactorVal66MetPolymorphism in Children With a Prepubertal and Early Adolescent Bipolar Disorder Phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300950

Mitochondrial nitric oxide synthase: a ubiquitous regulator of oxidative phosphorylation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300950

7 January 2021

Effects of antipsychotic drugs on metabolite ratios in rat brain in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300950

7 January 2021

The National Depressive and Manic-depressive Association (DMDA) survey of bipolar members

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300950

7 January 2021

Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine fumarate: an open-label trial in adolescents with psychotic disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300950

7 January 2021

Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300950

7 January 2021

Lithium-induced increase in human brain grey matter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300950

7 January 2021

Validation of a self-administered instrument to assess stage of adolescent development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300950

7 January 2021

Estimation of metabolite concentrations from localized in vivo proton NMR spectra

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300950

7 January 2021

In vivo olanzapine occupancy of muscarinic acetylcholine receptors in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300950

7 January 2021

Olanzapine in the treatment of adolescent acute mania: a report of seven cases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300950

7 January 2021

Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300950

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300950

1 reference

25 December 2017

Dimensions Publication ID

1000631958

0 references

1 reference

25 December 2017